Futura Medical shares rise on ED licensing deal with Haleon

by | Jul 17, 2023

(Sharecast News) – Shares in Futura Medical gained on Monday after the company said it signed a licensing deal with consumer heath care giant Haleon for the rights to exclusively commercialise its topical, gel-based erectile dysfunction treatment MED3000 in the USA.
Futura will receive an initial upfront payment of $4m, royalty payments on all sales of MED3000 by Haleon and potential commercial and performance-driven sales milestone payments totalling between $5m and $45m payable over the course of several years

Related articles

RS Group surges on Betaville report

RS Group surges on Betaville report

(Sharecast News) - RS Group surged on Tuesday after markets blog Betaville pointed to "a fresh round of takeover speculation" in one of its latest uncooked alerts. Betaville said that people following the situation have heard rumours that RS Group, a distributor of...

Latest Articles

London close: Stocks mixed on global economic jitters

London close: Stocks mixed on global economic jitters

(Sharecast News) - Stocks in London ended Tuesday on a varied note, reflecting global apprehensions around the Chinese economy and rising interest rates, while the shadow of a US credit warning from Moody's loomed large. The FTSE 100 saw a modest uptick, finishing...

JP Morgan reaches settlement with US Virgin Islands over Epstein case

RS Group surges on Betaville report

(Sharecast News) - RS Group surged on Tuesday after markets blog Betaville pointed to "a fresh round of takeover speculation" in one of its latest uncooked alerts. Betaville said that people following the situation have heard rumours that RS Group, a distributor of...

Deutsche Bank, Morgan Stanley cut Burberry price targets

Deutsche Bank, Morgan Stanley cut Burberry price targets

(Sharecast News) - Luxury fashion brand Burberry took a hit on Tuesday as both Morgan Stanley and Deutsche Bank cut their price targets on the stock. DB cut the price target to 2,200p from 2,240p, saying it's more cautious on trends in China and in the US and is...

Join our mailing list

Subscribe to our mailing list to receive regular updates!

No Fields Found.
x